Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion type Assertion NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_head.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion description "[Riboflavin is considered to be effective by activating the NADPH diaphorase (NADPH flavin reductase) system and appears to be useful for the treatment of congenital methaemoglobinaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion evidence source_evidence_literature NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion SIO_000772 6893937 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion wasDerivedFrom befree-20150227 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.
- NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_assertion wasGeneratedBy ECO_0000203 NP352235.RAl2Vy4xvlWaU51kIcrhIfoUiq721sNQ-PtY9ePsOJQs0130_provenance.